Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 9, 2004, Pages 981-988

  Panter, S J ^a,c   O'Flanagan, H ^a   Bramble, M G ^a   Hungin, A P S ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c SOUTH TYNESIDE DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL CARCINOMA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 2442657642     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01924.x     Document Type: Article

References (23)

1. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27.
2. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992; 1: 265-9.
3. Allum WH, Fielding JW. Gastric cancer: a 25-year review. Br J Surg 1990; 77: 353.
4. Wayman J, Craig DJ, Biggin CS, Raimes SA, Griffin SM. The changing pattern of oesophago-gastric cancer. Gut 1997; 40(3S, Suppl. 1): 8.
5. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
6. Devesa SS, Fraumeni JF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999; 91: 747-9.
7. Thomas RJ, Lade S, Giles GG, Thursfield V. Incidence trends in oesophageal and proximal gastric carcinoma in Victoria. Aust N Z J Surg 1996; 66: 271-5.
8. Wayman J, Raimes S, Griffin SM, Hayes N. Delays in diagnosing oesophagogastric cancer. Small study found that four fifths of delay was due to patients. BMJ 1997; 315: 428.
9. Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 1997; 314: 467-70.
10. Suvakovic Z, Bramble MG, Jones R, Wilson C, Idle N, Ryott J. Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut 1997; 41: 308-13.
11. Dyspepsia guidelines. 2003. http://www.sign.ac.uk
12. Wayman J, Hayes N, Griffin SM. The response of early gastric cancer to proton-pump inhibitors. N Engl J Med 1998; 338: 1924-5.
13. Kennedy BJ. The unified international gastric cancer staging classification. Scand J Gastroenterol 1987; 22(Suppl. 133): 11-3.
14. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
15. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998; 317: 452-6.
16. Jones MI, Greenfield SM, Jowett S, Bradley CP, Seal R. Proton pump inhibitors: a study of GPs' prescribing. Fam Pract 2001; 18: 333-8.
17. Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000; 46: 464-7.
18. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-86.
19. Bytzer P, Hansen JM, Schaffalitzky De Muckadell OB, Malchow-Moller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol 1997; 32: 118-25.
20. Hansen JM, Bytzer P, Schaffalitzky De Muckadell OB. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998; 33: 799-805.
21. Fujita S. Biology of early gastric carcinoma. Pathol Res Pract 1978; 163: 297-309.
22. Eckardt VF, Willems D, Kanzler G, Remmele W, Bettendorf U, Paulus W. Eighty months persistence of poorly differentiated early gastric cancer. Gastroenterology 1984; 87: 719-24.
23. Kohli Y, Kawai K, Fujita S. Analytical studies on growth of human gastric cancer. J Clin Gastroenterol 1981; 3: 129-33.